Vaccinogen Inc
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Multicenter Study of Active Specific Immunotherapy With OncoVax® in Patients With Stage II Colon Cancer (NCT02448173) | Vaccinogen Inc | 2026-08-01 |
Track Vaccinogen Inc automatically
Every clearance here is in the API, with alerts when new ones post.